Moreover, recent research reveals that Nrf2 activity may be elevated in cancer cells, and its cytoprotective action may promote cancer cell survival and proliferation, implying that inhibition of Nrf2 during cancer treatment may be essential (Lau et al., 2008; Kang et al., 2020). This evidence concerns the gene NFE2L2 and cancer.